Johnson & Johnson Asia Pacific Pte Ltd announced the official opening of its new Asia Pacific headquarters yesterday, reaffirming its commitment to advancing healthcare innovation in Singapore and the Asia Pacific region. The regional headquarters will lead collaborations and partnerships to co-create new global healthcare models which are at the forefront of innovation.
The new 15,800 sq. meter facility will bring together more than 1,000 employees from Johnson & Johnson’s pharmaceuticals, medical devices and consumer businesses in one single location to spearhead new ideas and frameworks for healthcare of the future
Apart from this, the regional headquarters will also boast a Design Lab, its first design lab outside of the United States; Leadership Lab, and Human Performance Institute.
“The shifts in population demographics, globalization and technology today require companies to move health forward faster than ever before.
“We believe that our new regional hub in Singapore coupled with our global scientific strength and strategic external collaborations will create enduring and impactful solutions that reimagine the future of health,” said Ms. Ai Hua Ong, Company Group Chair, Janssen, the pharmaceutical companies of Johnson & Johnson.
Speaking at the opening ceremony, Ms. Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board noted that, “The opening of J&J’s new APAC HQ marks yet another major milestone in our partnership and further cements Singapore’s position as an innovation hub for companies looking to create new businesses and solutions for Asia and beyond.
..Singapore’s extensive physical connectivity, world-class research capabilities and diverse talent pool has allowed companies to use Singapore as a base to coordinate a broad spectrum of regional functions, as well as embark on innovation activities. As companies continue to look to Asia as a key region to drive growth, Singapore is also strategically positioned to support global companies in uncovering the diverse and unmet healthcare needs of Asian consumers.”
The Leadership Lab aims to conduct over 200 leadership development classes and train 4,000 Asian leaders annually. As a think-tank, the Leadership Lab will create links with universities, research groups, governments, healthcare organizations and other partners to co-create new healthcare models and solutions to prototype capabilities required to author the next chapter of healthcare innovation in Asia
A first of its kind in Asia Pacific, Human Performance Institute will offer its proprietary leadership development initiatives to participants outside of Johnson & Johnson, with the goal to train 150,000 people in Singapore by 2020.
While appreciating the leadership development and health care education initiatives that J&J will help drive, Ms. Thien Kwee Eng concluded by saying that, “With Singapore’s emphasis on innovation as a growth-driver for companies, there is a need to prepare the workforce with the relevant skills and capabilities. EDB will continue to spearhead joint efforts with industry to understand the manpower needs of businesses, and work in tandem with training providers to build the necessary capabilities in our workforce.”